186 related articles for article (PubMed ID: 233248)
1. Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.
Skrabal F
J R Soc Med; 1979 Apr; 72(4):252-9. PubMed ID: 233248
[No Abstract] [Full Text] [Related]
2. Mineralocorticoids and mineralocorticoid receptors in mononuclear leukocytes in patients with pregnancy-induced hypertension.
Wacker J; E-Mistry N; Bauer H; Vecsei P; Stolz W; Bastert G
J Clin Endocrinol Metab; 1992 Apr; 74(4):910-3. PubMed ID: 1312541
[TBL] [Abstract][Full Text] [Related]
3. [A precise bioassay for in vivo mineralocorticoid activity in man: relation to plasma aldosterone in normal subjects, essential hypertension, hyperaldosteronism and adrenocortical insufficiency (author transl)].
Skrabal F
Wien Klin Wochenschr Suppl; 1977; 78():1-13. PubMed ID: 271428
[No Abstract] [Full Text] [Related]
4. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Biglieri EG; Kater CE
Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
[TBL] [Abstract][Full Text] [Related]
5. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
[No Abstract] [Full Text] [Related]
6. Forms of mineralocorticoid hypertension.
Ferrari P; Bonny O
Vitam Horm; 2003; 66():113-56. PubMed ID: 12852254
[TBL] [Abstract][Full Text] [Related]
7. [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].
Corvol P; Houde M; Benguigui L; Tonnelier M; Menard J; Milliez P
Nouv Presse Med; 1977 Sep; 6(29):2569-72. PubMed ID: 909737
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of a rapid test for the study of mineralocorticoid activity in the body].
Kiss R; Gláz E; Láng L; Rácz K; Varga I
Orv Hetil; 1983 Nov; 124(46):2789-92. PubMed ID: 6646743
[No Abstract] [Full Text] [Related]
9. Mineralocorticoid and glucocorticoid receptors in circulating mononuclear leukocytes of patients with primary hyperaldosteronism.
Armanini D; Witzgall H; Strasser T; Weber PC
Cardiology; 1985; 72 Suppl 1():99-101. PubMed ID: 2996770
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of mineralocorticoid hypertension.
Biglieri EG
Hypertension; 1991 Feb; 17(2):251-61. PubMed ID: 1846843
[No Abstract] [Full Text] [Related]
11. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
Fardella CE; Montero J; Mosso L
Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
Kawarazaki W; Fujita T
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
[TBL] [Abstract][Full Text] [Related]
13. Inter-relationships between plasma angiotensin II, arterial pressure, aldosterone and exchangeable sodium in normotensive and hypertensive man.
Beevers DG; Brown JJ; Cuesta V; Davies DL; Fraser R; Lebel M; Lever AF; Morton JJ; Oelkers W; Robertson JI; Schalekamp MA; Tree M
J Steroid Biochem; 1975 May; 6(5):779-84. PubMed ID: 1102803
[No Abstract] [Full Text] [Related]
14. [Binding of aldosterone to its receptors along the nephron of the normal and spontaneously hypertensive rat].
Farman N; Bonvalet JP
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1238-41. PubMed ID: 6240970
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone receptors in different types of primary hyperaldosteronism.
Armanini D; Witzgall H; Wehling M; Kuhnle U; Weber PC
J Clin Endocrinol Metab; 1987 Jul; 65(1):101-4. PubMed ID: 3034947
[TBL] [Abstract][Full Text] [Related]
16. Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Hundemer GL; Baudrand R; Brown JM; Curhan G; Williams GH; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1835-1843. PubMed ID: 28323995
[TBL] [Abstract][Full Text] [Related]
17. New aspects of mineralocorticoid hypertension.
Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia.
Kuhnle U; Land M; Ulick S
J Clin Endocrinol Metab; 1986 May; 62(5):934-40. PubMed ID: 3007560
[TBL] [Abstract][Full Text] [Related]
19. Subtraction potential difference: In-vivo assay for mineralocorticoid activity.
Skrabal F; Auböck J; Edwards CR; Braunsteiner H
Lancet; 1978 Feb; 1(8059):298-302. PubMed ID: 75336
[TBL] [Abstract][Full Text] [Related]
20. Inherited forms of mineralocorticoid hypertension.
Hassan-Smith Z; Stewart PM
Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):177-85. PubMed ID: 21494136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
